검색어 : 통합검색[Anderson Gillian]
총 494건 중 494건 출력
, 49/50 페이지
-
481
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
- Denduluri, Neelima; Somerfield, Mark R.; Chavez-MacGregor, Mariana; Comander, Amy H.; Dayao, Zoneddy; Eisen, Andrea; Freedman, Rachel A.; Gopalakrishnan, Ragisha; Graff, Stephanie L.; Hassett, Michael J.; King, Tari A.; Lyman, Gary H.; Maupin, Gillian Rice; Nunes, Raquel; Perkins, Cheryl L.; Telli, Melinda L.; Trudeau, Maureen E.; Wolff, Antonio C.; Giordano, Sharon H.; Virginia Cancer Specialists, US Oncology, Arlington, VA; American Society of Clinical Oncology, Alexandria, VA; The University of Texas MD Anderson Cancer Center, Houston, TX; Massachusetts General Hospital Center at Newton-Wellesley, Newton, MA; University of New Mexico Hospital, Albuquerque, NM; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Dana-Farber Cancer Institute, Boston, MA; Rocky Mountain Cancer Centers, Colorado Springs, CO; Sarah Cannon Cancer Institute, HCA Midwest Health, Kansas City, MO; Dana-Farber Cancer Institute, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Fred Hutchinson Cancer Research Center, Seattle, WA; Virginia Hospital Center, Arlington, VA Lowe & Carlo, Alexandria, VA; Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD; Patient representative, Dallas, TX; Stanford University School of Medicine, Stanford, CA; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Sidney Kimmel Cancer Center,; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.685-693)
-
482
- Development of standard definitions and grading for Maternal and Fetal Adverse Event Terminology
-
Spencer, Rebecca N.;
Hecher, Kurt;
Norman, Gill;
Marsal, Karel;
Deprest, Jan;
Flake, Alan;
Figueras, Francesc;
Lees, Christoph;
Thornton, Steve;
Beach, Kathleen;
Powell, Marcy;
Crispi, Fatima;
Diemert, Anke;
Marlow, Neil;
Peebles, Donald M.;
Westgren, Magnus;
Gardiner, Helena;
Gratacos, Eduard;
Brodszki, Jana;
Batista, Albert;
Turier, Helen;
Patel, Mehali;
Power, Beverley;
Power, James;
Yaz, Gillian;
David, Anna L.;
School of Medicine, University of Leeds, Leeds, UK;
Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg‐
Eppendorf, Hamburg, Germany;
Division of Nursing, Midwifery & Social Work, Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, UK;
Lund University, Lund, Sweden;
Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK;
Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA;
Institut D’Investigacions Biomè
diques August Pi ì
Sunyer, Barcelona, Spain;
Queen Charlottes and Chelsea Hospital, Imperial College London, London, UK
-
483
- A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract
- Ponce, Doris M.; Alousi, Amin M.; Nakamura, Ryotaro; Sandhu, Karamjeet S.; Barker, Juliet N.; Shia, Jinru; Yan, Xiaoqiang; Daley, William L.; Moore, Gillian; Fatmi, Samira; Soto, Cristina; Gomes, Antonio; Slingerland, John; Giardina, Paul; Peled, Jonathan U.; van den Brink, Marcel R.M.; Hanash, Alan M.; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center; Department of Pathology, Memorial Sloan Kettering Cancer Center; Generon (Shanghai) Corporation; Generon (Shanghai) Corporation; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center; Sloan Kettering Institute, Memorial Sloan; (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, v.26, 2020, pp.S51-S52)
-
484
- Abstract A026: An alternative to HER2 IHC 0/1+/2+ status to predict which clinically HER2-negative patients will respond to anti-HER2 therapies: A rationale for the likely superiority of quantitative HER2 pathway RPPA measurements
- Wulfkuhle, Julia; Wolf, Denise M.; DeMichele, Angela; Yau, Christina; van ‘t Veer, Laura; Rugo, Hope S.; Pusztai, Lajos; Brown-Swigart, Lamorna; Hirst, Gillian L.; Gallagher, Rosa I.; Delson, Amy L.; Borowsky, Alexander D.; Esserman, Laura J.; Pohlmann, Paula R.; Petricoin, Emanuel F.; 1George Mason University, Fairfax, VA,; 2University of California San Francisco, San Francisco, CA,; 3University of Pennsylvania, Philadelphia, PA,; 2University of California San Francisco, San Francisco, CA,; 4UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,; 4UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,; 5Yale University School of Medicine, New Haven, CT,; 2University of California San Francisco, San Francisco, CA,; 2University of California San Francisco, San Francisco, CA,; 1George Mason University, Fairfax, VA,; 2University of California San Francisco, San Francisco, CA,; 6University of California Davis, Sacramento, CA,; 2University of California San Francisco, San Francisco, CA,; 7MD Anderson Cancer Center, Houston, TX,; 8George Mason University, Manassas, VA.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.A026-A026)
-
485
- Abstract B019: Clinical and molecular correlates of circulating tumor DNA (ctDNA) dynamics in breast tumors resistant to neoadjuvant therapy (NAT)
- Magbanua, Mark Jesus M.; Wolf, Denise M.; Rivera-Hinojosa, Samuel; Ahmed, Ziad; Manon, Nayelis A.; Sayaman, Rosalyn; Tin, Antony; Kalashnikova, Ekaterina; Swigart, Lamorna Brown; Hirst, Gillian L.; Yau, Christina; Li, Wen; Isaacs, Claudine; Shatsky, Rebecca A.; Delson, Amy L.; Palsuledesai, Charuta C.; Rodriguez, Angel; Liu, Minetta C.; Pohlmann, Paula R.; Esserman, Laura J.; Rugo, Hope S.; DeMichele, Angela; Veer, Laura van 't; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 2Natera, San Carlos, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 2Natera, San Carlos, CA,; 2Natera, San Carlos, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 3Georgetown University, Washington DC,; 4University of California San Diego, San Diego, CA,; 1University of California San Francisco, San Francisco, CA,; 2Natera, San Carlos, CA,; 2Natera, San Carlos, CA,; 2Natera, San Carlos, CA,; 5MD Anderson Cancer Center, Houston, TX,; 1University of California San Francisco, San Francisco, CA,; 1University of Cal; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.30, 2024, pp.B019-B019)
-
486
- Abstract A014: Cell-free DNA concentration as a biomarker of response and recurrence in HER-2 negative breast cancer receiving neoadjuvant chemotherapy
- Magbanua, Mark Jesus M.; Ahmed, Ziad; Sayaman, Rosalyn W.; Brown-Swigart, Lamorna; Hirst, Gillian L.; Yau, Christina; Wolf, Denise M.; Li, Wen; Delson, Amy L.; Perlmutter, Jane; Symmans, W. Fraser; Yee, Douglas; Hylton, Nola M.; Esserman, Laura J.; DeMichele, Angela M.; Rugo, Hope S.; van ’t Veer, Laura J.; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 2UCSF Breast Science Advocacy Core, San Francisco, CA,; 2UCSF Breast Science Advocacy Core, San Francisco, CA,; 3University of Texas MD Anderson Cancer Center, Houston, TX,; 4University of Minnesota, Minneapolis, MN,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 5University of Pennsylvania, Philadelphia, PA.; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Fr; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.A014-A014)
-
487
- Abstract B077: Subtype-specific signaling dynamics during treatment in non-responding breast cancer patients in the neoadjuvant I-SPY2 TRIAL: are there clues on how to overcome resistance?
- Wolf, Denise M.; Yau, Christina; Magbanua, Mark Jesus M.; Sayaman, Rosalyn; Wulfkhule, Julia; Gallagher, Rosa I.; Brown-Swigart, Lamorna; Campbell, Michael J.; Basu, Amrita; Hirst, Gillian L.; Perlmutter, Jane; DeMichele, Angela; Yee, Doug; Pusztai, Lajos; Pohlmann, Paula R.; Clark, Amy S.; Rugo, Hope S.; Petricoin, Emanuel F.; Esserman, Laura J.; van ‘t Veer, Laura; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 2George Mason University, Fairfax, VA,; 2George Mason University, Fairfax, VA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 1University of California San Francisco, San Francisco, CA,; 3UCSF Breast Science Advocacy Core, San Francisco, CA,; 4University of Pennsylvania, Philadelphia, PA,; 5University of Minnesota, Minneapolis, MN,; 6Yale University School of Medicine, New Haven, CT,; 7MD Anderson Cancer Center, Houston, TX,; 4University of Pennsylvania, Philadelphia, PA,; 1University of California San Francisco, San Francisco, CA,; 8George Mason University, Manassas, VA.; 1University of Califo; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.B077-B077)
-
488
- Abstract GS4-02: Analysis of clinical outcomes and expression-based immune signatures by race in the I-SPY 2 trial
- Kyalwazi, Beverly; Yau, Christina; Olopade, Olufunmilayo; Chien, A. Jo; Wallace, Anne; Forero-Torres, Andres; Pusztai, Lajos; Ellis, Erin; Albain, Kathy; Blaes, Anne; Haley, Barbara; Boughey, Judy; Elias, Anthony; Clark, Amy; Isaacs, Claudine; Nanda, Rita; Han, Hyo; Yung, Rachel; Tripathy, Debu; Edmiston, Kristen; Viscusi, Rebecca; Northfelt, Donald; Khan, Qamar; Sanil, Ashish; Berry, Scott; Asare, Smita; Wilson, Amy; Hirst, Gillian; Hylton, Nola; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope; Symmans, Fraser; van ‘t Veer, Laura; Berry, Donald; Esserman, Laura; University of Chicago Pritzker School of Medicine, Chicago, IL; ; University of California San Francisco, San Francisco, CA; ; University of Chicago, Chicago, IL; ; University of California San Francisco, San Francisco, CA; ; University of California San Diego, San Diego, CA; ; University of Alabama at Birmingham, Birmingham, AL; ; University of Texas MD Anderson Cancer Center, Houston, TX; ; Swedish Cancer Institute, Seattle, WA; ; Loyola University Chicago Stritch School of Medicine, Chicago, IL; ; University of Minnesota, Minneapolis, MN; ; University of Texas Southwestern, Dallas, TX; ; Mayo Clinic Rochester, Rochester, MN; ; University of Colorado, Denver, CO; ; University of Pennsylvania, Philadelphia, PA; ; Georgetown, Washington, DC; ; University of Chicago, Chicago, IL; ; Moffitt Cancer Center, Tampa, FL; ; University of Washington, Seattle, WA; ; University of Southern California, Los Angeles, CA; ; Inova Health System, Falls Church, VA; ; University of Arizona, Phoenix, AZ; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.82, 2022, pp.GS4-02-GS4-02)
-
489
- A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
- Ponce, Doris M.; Alousi, Amin M.; Nakamura, Ryotaro; Slingerland, John; Calafiore, Marco; Sandhu, Karamjeet S.; Barker, Juliet N.; Devlin, Sean; Shia, Jinru; Giralt, Sergio; Perales, Miguel-Angel; Moore, Gillian; Fatmi, Samira; Soto, Cristina; Gomes, Antonio; Giardina, Paul; Marcello, LeeAnn; Yan, Xiaoqiang; Tang, Tom; Dreyer, Kevin; Chen, Jianmin; Daley, William L.; Peled, Jonathan U.; van den Brink, Marcel R. M.; Hanash, Alan M.; 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; 3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; 4Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA; 5Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY; 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; 4Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA; 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; 6Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY; 7Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY; 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; 1Department of Medicine,; (Blood, v.141, 2023, pp.1389-1401)
-
490
- Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
- Boughey, Judy C.; Alvarado, Michael D.; Lancaster, Rachael B.; Symmans, W. Fraser; Mukhtar, Rita; Wong, Jasmine M.; Ewing, Cheryl A.; Potter, David A.; Tuttle, Todd M.; Hieken, Tina J.; Carter, Jodi M.; Jakub, James W.; Kaplan, Henry G.; Buchanan, Claire L.; Jaskowiak, Nora T.; Sattar, Husain A.; Mueller, Jeffrey; Nanda, Rita; Isaacs, Claudine J.; Pohlmann, Paula R.; Lynce, Filipa; Tousimis, Eleni A.; Zeck, Jay C.; Lee, M. Catherine; Lang, Julie E.; Mhawech-Fauceglia, Paulette; Rao, Roshni; Taback, Bret; Goodellas, Constantine; Chen, Margaret; Kalinsky, Kevin M.; Hibshoosh, Hanina; Killelea, Brigid; Sanft, Tara; Hirst, Gillian L.; Asare, Smita; Matthews, Jeffrey B.; Perlmutter, Jane; Esserman, Laura J.; Department of Surgery, Mayo Clinic, Rochester, MN USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL USA; Department of Pathology, MD Anderson Cancer Center, Houston, TX USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; UCSF Heller Diller Family Comprehensive Cancer Center, San Francisco, CA USA; Department of Medicine, University of Minnesota, Minneapolis, MN USA; Department of Surgery, University of Minnesota, Minneapolis, MN USA; Department of Surgery, Mayo Clinic, Rochester, MN USA; Department of Pathology, Mayo Clinic, Rochester, MN USA; Department of Surgery, Mayo Clinic, Rochester, MN USA; Swedish, Swedish Cancer Institute, Seattle, WA USA; Swedish, Swedish Cancer Institute, Seattle, WA USA; Department of Surgery, University of Chicago, Chicago, IL US; (NPJ breast cancer, v.5, 2019, pp.2)
QUICK MENU
